Clearance Summary
Acumen Hypotension Prediction Index, HemoSphere Advanced Monitoring Platform received FDA 510(k) clearance under submission number K203224, sponsored by Edwards Lifesciences, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2021-07-30.
- Submission: K203224
- Applicant / Sponsor: Edwards Lifesciences, LLC
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2210
- Decision date: 2021-07-30
Classification & Regulation
This clearance is catalogued under FDA product code QAQ and 21 CFR 870.2210, within the Cardiovascular review panel as a Class II device.